Legal & General Group
NMTR

Legal & General Group’s 9 Meters Biopharma NMTR Stock Holding History

Legal & General Group’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,183
Closed -$14K – 3724
2022
Q1 		$14K Buy
1,183
+59
+5% +$806 ﹤0.01% 3332
2021
Q4 		$22K Hold
1,124
– – ﹤0.01% 3255
2021
Q3 		$29K Hold
1,124
– – ﹤0.01% 3141
2021
Q2 		$25K Buy
+1,124
New +$27.6K ﹤0.01% 3217
2019
Q3 		– Sell
-138
Closed -$3K – 3439
2019
Q2 		$3K Hold
138
– – ﹤0.01% 3470
2019
Q1 		$5K Hold
138
– – ﹤0.01% 3314
2018
Q4 		$6K Hold
138
– – ﹤0.01% 3326
2018
Q3 		$19K Hold
138
– – ﹤0.01% 3227
2018
Q2 		$65K Buy
+138
New +$50.8K ﹤0.01% 2639

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWM
Curi Wealth Management Raleigh, North Carolina $724M AUM 17.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Legal & General Group's NMTR Position: Q2 2022 in Review

Legal & General Group sold out of 9 Meters Biopharma (NMTR) in Q2 2022, closing a stake of 1,183 shares — an estimated $14K sold.

Legal & General Group first reported a position in NMTR in Q2 2018 and held it in 9 quarters. The position peaked at $65K in Q2 2018. 88 funds tracked by Wall St. Rank hold NMTR as of Q2 2022.

  • Legal & General Group reported no remaining 9 Meters Biopharma position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 1,183 9 Meters Biopharma shares in Q2 2022, an estimated $14K.
  • Legal & General Group first reported a position in 9 Meters Biopharma in Q2 2018 and held it in 9 quarters.
  • Legal & General Group's 9 Meters Biopharma position peaked at $65K in Q2 2018.
  • 88 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.